Newsfeeds - Spark Newswire

2 minute read

FDA
News

COMPASS Pathways, Kings College London Publish Cognition Results From COMP360 Psilocybin Study In Healthy Volunteers

Today, 3:53 AM

COMPASS Pathways plc (NASDAQ:CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I

CMPS

4 minute read

Cannabis
Markets
Small Cap

Meet PsyBio, A Company Producing Psilocybin From Genetically-Modified Bacteria

By Natan Ponieman

Today, 3:53 AM

As psychedelics draw closer to legalization, companies in the industry have yet to figure out the most efficient and cost-effective way of producing psilocybin and other molecules on a commercial scale.

CMPS

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

By Benzinga Insights

Today, 3:53 AM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

Latest news

COMPASS Pathways, Kings College London Publish Cognition Results From COMP360 Psilocybin Study In Healthy Volunteers

Meet PsyBio, A Company Producing Psilocybin From Genetically-Modified Bacteria

Earnings Scheduled For May 13, 2021